Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7514355 | 1.00 | BCHE (0.33) | BCHEEZH2HTR2CSLC6A4 | |
| SCHEMBL1388984 | 1.00 | BCHE (0.33) | BCHEEZH2HTR2CSLC6A4 | |
| SCHEMBL1717405 | 1.00 | BCHE (0.33) | BCHEEZH2HTR2CSLC6A4 | |
| SCHEMBL12632563 | 1.00 | BCHE (0.33) | BCHEEZH2HTR2CSLC6A4 | |
| Hydrochloric Acid SCHEMBL7513256 | 0.99 | BCHE (0.33) | BCHEEZH2HTR2CSLC6A4 | |
| Hydrochloric Acid SCHEMBL7513262 | 0.99 | BCHE (0.33) | BCHEEZH2HTR2CSLC6A4 | |
| SCHEMBL7525880 | 0.99 | BCHE (0.32) | BCHEEZH2 | |
| SCHEMBL7525881 | 0.99 | BCHE (0.32) | BCHEEZH2 | |
| SCHEMBL7526413 | 0.96 | PTGER1 (0.31) | — | |
| SCHEMBL7526409 | 0.96 | PTGER1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| EP-0686147-B1 | NOVEL 2,2'-BI-1H-PYRROLE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | PHARMACIA ITALIA SPA (IT) | 2002-09-25 | — | — | EP | claimed |
| EP-0866701-B1 | SYNERGISTIC IMMUNOSUPPRESSANT COMPOSITION CONTAINING A 2,2'-BI-1H-PYRROLE COMPOUND | PHARMACIA & UPJOHN SPA (IT) | 2002-01-16 | — | — | EP | claimed |
| EP-0825983-B1 | PROCESS FOR THE PREPARATION OF 2,2'-BIPYRROLYL-PYRROMETHENE (PRODIGIOSINS) DERIVATIVES | PHARMACIA & UPJOHN SPA (IT) | 2001-08-29 | — | — | EP | claimed |
| EP-0975338-A2 | 2,2'-BI-1H-PYRROLE DERIVATIVES USEFUL IN THE TREATMENT OF LEUKEMIA BROUGHT ON BY HTLV-I | PHARMACIA & UPJOHN S.p.A. (IT) | 2000-02-02 | — | — | EP | claimed |
| WO-1999029309-A2 | 2,2'-BI-1H-PYRROLE DERIVATIVES USEFUL IN THE TREATMENT OF LEUKEMIA BROUGHT ON BY HTLV-I | PHARMACIA & UPJOHN S.P.A. (IT) | 1999-06-17 | — | — | WO | claimed |
| EP-0866701-A1 | SYNERGISTIC IMMUNOSUPPRESSANT COMPOSITION CONTAINING A 2,2'-BI-1H-PYRROLE COMPOUND | PHARMACIA & UPJOHN S.p.A. (IT) | 1998-09-30 | — | — | EP | claimed |
| WO-1998011894-A1 | SYNERGISTIC IMMUNOSUPPRESSANT COMPOSITION CONTAINING A 2,2'-BI-1H-PYRROLE COMPOUND | PHARMACIA & UPJOHN S.P.A. (IT) | 1998-03-26 | — | — | WO | claimed |
| US-5691334-A | IMMUNOMODULATORS FOR SKIN GRAFTS, AUTOIMMUNE AND FOR ORGAN TRANSPLANTS | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-11-25 | — | — | US | claimed |
| JP-H08507090-A | — | — | 1996-07-30 | — | — | JP | claimed |
| EP-0686147-A1 | NOVEL 2,2'-BI-1H-PYRROLE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | PHARMACIA & UPJOHN S.p.A. (IT) | 1995-12-13 | — | — | EP | claimed |
| WO-1995017381-A1 | NOVEL 2,2'-BI-1H-PYRROLE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | PHARMACIA S.P.A. (IT) | 1995-06-29 | — | — | WO | claimed |
| US-20260055116-A1 | SUBSTITUTED TETRAHYDROPYRROLO-PYRIDINONE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | KARUNA THERAPEUTICS INC (US) | 2026-02-26 | — | — | US | disclosed |
| US-20250333441-A1 | POLYPEPTIDE INHIBITORS AND USES THEREOF | NEURACLE SCIENCE CO., LTD. (KR) | 2025-10-30 | — | — | US | disclosed |
| EP-4634194-A1 | SUBSTITUTED DIHYDROPYRROLO [3, 4-D] PYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | Karuna Therapeutics, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4634193-A1 | SUBSTITUTED DIHYDROPYRROLO[3, 4-D]PYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | Karuna Therapeutics, Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| WO-1998011894-A1 | SYNERGISTIC IMMUNOSUPPRESSANT COMPOSITION CONTAINING A 2,2'-BI-1H-PYRROLE COMPOUND | PHARMACIA & UPJOHN S.P.A. (IT) | 1998-03-26 | — | — | WO | disclosed |
| US-5691334-A | IMMUNOMODULATORS FOR SKIN GRAFTS, AUTOIMMUNE AND FOR ORGAN TRANSPLANTS | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-11-25 | — | — | US | disclosed |
| EP-0686147-A1 | NOVEL 2,2'-BI-1H-PYRROLE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | PHARMACIA & UPJOHN S.p.A. (IT) | 1995-12-13 | — | — | EP | disclosed |
| WO-1995017381-A1 | NOVEL 2,2'-BI-1H-PYRROLE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | PHARMACIA S.P.A. (IT) | 1995-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | TACR1, ACHE, TACR2 | BCHE 8/4885EZH2 4248/4885HTR2C 390/4885 |
| US-20250333441-A1 | POLYPEPTIDE INHIBITORS AND USES THEREOF | LRRC59, FAM20C, LRRFIP1 | BCHE 3527/4885EZH2 4373/4885HTR2C 4668/4885 |
| US-20260055116-A1 | SUBSTITUTED TETRAHYDROPYRROLO-PYRIDINONE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS | CHRM3, CHRM2, CHRM1 | BCHE 530/4885EZH2 4006/4885HTR2C 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.